£83.26

About as cheap as it gets — within 5% of the all-time low it hit 1 month ago.

£83 today · all-time low £82 (Sep 2026) · usually £82

Springer Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 77 days · 77 data points (no recent data)

Historical
Generating forecast…
£85.86 £81.87 £82.74 £83.61 £84.48 £85.35 £86.22 25 July 2026 13 August 2026 01 September 2026 20 September 2026 09 October 2026
View at Amazon ↗

Price data last checked 14 day(s) ago - will refresh soon

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 77 days • 3 price levels

Days at Price
Current Price
21 days 1 day · current 55 days 0 14 28 41 55 £82 £83 £86 Days at Price

Price Analysis

Most common price: £86 (55 days, 71.4%)

Price range: £82 - £86

Price levels: 3 different prices over 77 days

Description

Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways. This monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry.

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
11 November 2010
Listed Since
18 December 2009

Barcode

No barcode data available

Similar Products You Might Like

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
98% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.11 12 Sep 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
97% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.11 04 Oct 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
97% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 11 Sep 2026
Multiple Myeloma & Plasma Cell Neoplasms Clinical Guide
97% match

Multiple Myeloma & Plasma Cell Neoplasms Clinical Guide

Springer

£111.67 08 Oct 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
97% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 12 Aug 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
97% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£80.67 24 Sep 2026
Biology and Management of Multiple Myeloma (Current Clinical Oncology)
97% match

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Humana

£69.13 24 Sep 2026
Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia
96% match

Molecular Pathogenesis and Treatment of Chronic Myelogenous Leukemia

Springer

£109.99 13 Aug 2026
Biology and Management of Multiple Myeloma (Current Clinical Oncology)
96% match

Biology and Management of Multiple Myeloma (Current Clinical Oncology)

Humana

£113.76 03 Oct 2026
Advances in Biology and Therapy of Multiple Myeloma Volume 2
96% match

Advances in Biology and Therapy of Multiple Myeloma Volume 2

Springer

£111.90 13 Oct 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
96% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.27 13 Aug 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
96% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£73.48 13 Oct 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
96% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£92.80 25 Sep 2026
Treatment of Multiple Myeloma and Related Disorders
96% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 17 Sep 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
96% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Elsevier

£167.99 22 Aug 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
96% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£61.58 23 Sep 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
96% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£148.94 14 Aug 2026
Über die Lebensqualität von Patienten mit akuter myeloischer Leukämie: Eine differenzierende Beobachtungsstudie
96% match

Über die Lebensqualität von Patienten mit akuter myeloischer Leukämie: Eine differenzierende Beobachtungsstudie

Südwestdeutscher Verlag für Hochschulschriften

£68.00 14 Oct 2026
Consulting Hematology and Oncology Handbook
96% match

Consulting Hematology and Oncology Handbook

Springer

£59.97 23 Sep 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£144.43 20 Aug 2026
Horizons in Cancer Research. Volume 73: Volume 73
96% match

Horizons in Cancer Research. Volume 73: Volume 73

£112.65 15 Aug 2026
Tumors of the Bone Marrow (Atlas of Tumor Pathology, Series 4): No. 24
96% match

Tumors of the Bone Marrow (Atlas of Tumor Pathology, Series 4): No. 24

£125.89 19 Aug 2026
Hematologic Malignancies in Adults
96% match

Hematologic Malignancies in Adults

Oncology Nursing Society

Price unavailable
Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)
96% match

Targeted Therapy of Acute Myeloid Leukemia (Current Cancer Research)

Springer

£109.08 11 Aug 2026